Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Rpl17 | Rat | (+)-catechin | multiple interactions | ISO | RPL17 (Homo sapiens) | 6480464 | [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of RPL17 mRNA | CTD | PMID:24763279 | Rpl17 | Rat | (-)-demecolcine | decreases expression | ISO | RPL17 (Homo sapiens) | 6480464 | Demecolcine results in decreased expression of RPL17 mRNA | CTD | PMID:23649840 | Rpl17 | Rat | (-)-epigallocatechin 3-gallate | increases expression | ISO | RPL17 (Homo sapiens) | 6480464 | epigallocatechin gallate results in increased expression of RPL17 protein | CTD | PMID:31195006 | Rpl17 | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Rpl17 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RPL17 mRNA | CTD | PMID:36331819 | Rpl17 | Rat | 1,2-dichloroethane | increases expression | ISO | Rpl17 (Mus musculus) | 6480464 | ethylene dichloride results in increased expression of RPL17 mRNA | CTD | PMID:28960355 | Rpl17 | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Rpl17 (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RPL17 mRNA | CTD | PMID:22206623 | Rpl17 | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | Rpl17 (Mus musculus) | 6480464 | 2,2',4,4'-tetrabromodiphenyl ether affects the expression of RPL17 mRNA | CTD | PMID:30294300 | Rpl17 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Rpl17 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of RPL17 mRNA | CTD | PMID:16214954 | Rpl17 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RPL17 mRNA | CTD | PMID:33387578 | Rpl17 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of RPL17 mRNA | CTD | PMID:34747641 | Rpl17 | Rat | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of RPL17 mRNA | CTD | PMID:21346803 | Rpl17 | Rat | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of RPL17 mRNA | CTD | PMID:21346803 | Rpl17 | Rat | 2-bromohexadecanoic acid | multiple interactions | ISO | RPL17 (Homo sapiens) | 6480464 | 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in more ... | CTD | PMID:38195004 | Rpl17 | Rat | 2-nitrofluorene | increases expression | EXP | | 6480464 | 2-nitrofluorene results in increased expression of RPL17 mRNA | CTD | PMID:15890375 | Rpl17 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RPL17 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Rpl17 | Rat | 4,4'-sulfonyldiphenol | affects expression | ISO | Rpl17 (Mus musculus) | 6480464 | bisphenol S affects the expression of RPL17 mRNA | CTD | PMID:39298647 | Rpl17 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | RPL17 (Homo sapiens) | 6480464 | bisphenol S results in increased expression of RPL17 protein | CTD | PMID:34186270 | Rpl17 | Rat | 4,4'-sulfonyldiphenol | decreases methylation | ISO | RPL17 (Homo sapiens) | 6480464 | bisphenol S results in decreased methylation of RPL17 gene | CTD | PMID:31601247 | Rpl17 | Rat | 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases expression | EXP | | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of RPL17 mRNA | CTD | PMID:15890375 | Rpl17 | Rat | 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole | affects expression | EXP | | 6480464 | Omeprazole affects the expression of RPL17 mRNA | CTD | PMID:19483382 | Rpl17 | Rat | 6-propyl-2-thiouracil | affects expression | EXP | | 6480464 | Propylthiouracil affects the expression of RPL17 mRNA | CTD | PMID:19483382 | Rpl17 | Rat | acrolein | multiple interactions | ISO | RPL17 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... | CTD | PMID:32699268|PMID:32845096 | Rpl17 | Rat | acrolein | increases expression | EXP | | 6480464 | Acrolein results in increased expression of RPL17 mRNA | CTD | PMID:38090360 | Rpl17 | Rat | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of RPL17 mRNA | CTD | PMID:15890375 | Rpl17 | Rat | alpha-pinene | multiple interactions | ISO | RPL17 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... | CTD | PMID:32699268 | Rpl17 | Rat | amiodarone | affects expression | EXP | | 6480464 | Amiodarone affects the expression of RPL17 mRNA | CTD | PMID:19483382 | Rpl17 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of RPL17 mRNA | CTD | PMID:16483693 | Rpl17 | Rat | antimycin A | increases expression | ISO | RPL17 (Homo sapiens) | 6480464 | Antimycin A results in increased expression of RPL17 mRNA | CTD | PMID:33512557 | Rpl17 | Rat | arsenite(3-) | multiple interactions | ISO | RPL17 (Homo sapiens) | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to RPL17 mRNA]; arsenite promotes the reaction [G3BP1 more ... | CTD | PMID:32406909 | Rpl17 | Rat | arsenous acid | decreases expression | ISO | RPL17 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of RPL17 mRNA | CTD | PMID:12852829 | Rpl17 | Rat | arsenous acid | increases expression | ISO | RPL17 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of RPL17 mRNA | CTD | PMID:20458559 | Rpl17 | Rat | azoxystrobin | increases expression | ISO | RPL17 (Homo sapiens) | 6480464 | azoxystrobin results in increased expression of RPL17 mRNA | CTD | PMID:33512557 | Rpl17 | Rat | benzbromarone | affects expression | EXP | | 6480464 | Benzbromarone affects the expression of RPL17 mRNA | CTD | PMID:19483382 | Rpl17 | Rat | benzo[a]pyrene | increases expression | ISO | Rpl17 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of RPL17 mRNA | CTD | PMID:19770486 | Rpl17 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of RPL17 mRNA | CTD | PMID:25181051|PMID:30816183|PMID:41034487 | Rpl17 | Rat | bisphenol A | multiple interactions | ISO | RPL17 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of RPL17 gene | CTD | PMID:31601247 | Rpl17 | Rat | bisphenol A | decreases expression | ISO | Rpl17 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of RPL17 mRNA | CTD | PMID:33221593 | Rpl17 | Rat | bisphenol A | affects expression | ISO | RPL17 (Homo sapiens) | 6480464 | bisphenol A affects the expression of RPL17 mRNA | CTD | PMID:30903817 | Rpl17 | Rat | bisphenol A | decreases expression | ISO | RPL17 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of RPL17 mRNA; bisphenol A results in decreased expression more ... | CTD | PMID:29275510|PMID:34186270|PMID:37567409 | Rpl17 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of RPL17 gene | CTD | PMID:28505145 | Rpl17 | Rat | bisphenol A | increases expression | ISO | Rpl17 (Mus musculus) | 6480464 | bisphenol A results in increased expression of RPL17 mRNA | CTD | PMID:25594700|PMID:32156529|PMID:38074096 | Rpl17 | Rat | bisphenol AF | increases expression | ISO | RPL17 (Homo sapiens) | 6480464 | bisphenol AF results in increased expression of RPL17 protein | CTD | PMID:34186270 | Rpl17 | Rat | bisphenol AF | increases expression | EXP | | 6480464 | bisphenol AF results in increased expression of RPL17 mRNA | CTD | PMID:39938710 | Rpl17 | Rat | Bisphenol B | increases expression | ISO | RPL17 (Homo sapiens) | 6480464 | bisphenol B results in increased expression of RPL17 protein | CTD | PMID:34186270 | Rpl17 | Rat | bisphenol F | multiple interactions | ISO | RPL17 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Rpl17 | Rat | bisphenol F | increases expression | ISO | RPL17 (Homo sapiens) | 6480464 | bisphenol F results in increased expression of RPL17 protein | CTD | PMID:34186270 | Rpl17 | Rat | bisphenol F | decreases expression | ISO | Rpl17 (Mus musculus) | 6480464 | bisphenol F results in decreased expression of RPL17 mRNA | CTD | PMID:38685157 | Rpl17 | Rat | cadmium atom | multiple interactions | ISO | RPL17 (Homo sapiens) | 6480464 | 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in more ... | CTD | PMID:38195004 | Rpl17 | Rat | cadmium dichloride | multiple interactions | ISO | RPL17 (Homo sapiens) | 6480464 | 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in more ... | CTD | PMID:38195004 | Rpl17 | Rat | caffeine | increases expression | ISO | RPL17 (Homo sapiens) | 6480464 | Caffeine results in increased expression of RPL17 protein | CTD | PMID:31195006 | Rpl17 | Rat | caffeine | decreases phosphorylation | ISO | RPL17 (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of RPL17 protein | CTD | PMID:35688186 | Rpl17 | Rat | carbon nanotube | multiple interactions | ISO | RPL17 (Homo sapiens) | 6480464 | [Nanotubes, Carbon co-treated with calfactant] results in increased expression of RPL17 protein | CTD | PMID:23026733 | Rpl17 | Rat | carbon nanotube | increases expression | ISO | Rpl17 (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in increased expression of RPL17 mRNA; Nanotubes, Carbon results in increased more ... | CTD | PMID:25554681 | Rpl17 | Rat | chloropicrin | decreases expression | ISO | RPL17 (Homo sapiens) | 6480464 | chloropicrin results in decreased expression of RPL17 mRNA | CTD | PMID:26352163 | Rpl17 | Rat | chromium(6+) | affects expression | ISO | Rpl17 (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of RPL17 mRNA | CTD | PMID:28472532 | Rpl17 | Rat | clofibrate | affects expression | EXP | | 6480464 | Clofibrate affects the expression of RPL17 mRNA | CTD | PMID:19483382 | Rpl17 | Rat | copper(II) sulfate | decreases expression | ISO | RPL17 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of RPL17 mRNA | CTD | PMID:19549813 | Rpl17 | Rat | deguelin | increases expression | ISO | RPL17 (Homo sapiens) | 6480464 | deguelin results in increased expression of RPL17 mRNA | CTD | PMID:33512557 | Rpl17 | Rat | deoxynivalenol | increases expression | ISO | RPL17 (Homo sapiens) | 6480464 | deoxynivalenol results in increased expression of RPL17 protein | CTD | PMID:39638853 | Rpl17 | Rat | dexamethasone | multiple interactions | ISO | RPL17 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Rpl17 | Rat | diarsenic trioxide | increases expression | ISO | RPL17 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of RPL17 mRNA | CTD | PMID:20458559 | Rpl17 | Rat | diarsenic trioxide | decreases expression | ISO | RPL17 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of RPL17 mRNA | CTD | PMID:12852829 | Rpl17 | Rat | dibenzo[a,l]pyrene | increases expression | ISO | Rpl17 (Mus musculus) | 6480464 | dibenzo(a,l)pyrene results in increased expression of RPL17 mRNA | CTD | PMID:25908611 | Rpl17 | Rat | Dibutyl phosphate | affects expression | ISO | RPL17 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of RPL17 mRNA | CTD | PMID:37042841 | Rpl17 | Rat | diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of RPL17 mRNA | CTD | PMID:15890375 | Rpl17 | Rat | diquat | increases expression | ISO | Rpl17 (Mus musculus) | 6480464 | Diquat results in increased expression of RPL17 protein | CTD | PMID:36851058 | Rpl17 | Rat | disodium selenite | increases expression | ISO | RPL17 (Homo sapiens) | 6480464 | Sodium Selenite results in increased expression of RPL17 mRNA | CTD | PMID:18175754 | Rpl17 | Rat | diuron | decreases expression | ISO | RPL17 (Homo sapiens) | 6480464 | Diuron results in decreased expression of RPL17 mRNA | CTD | PMID:35967413 | Rpl17 | Rat | doxorubicin | affects expression | ISO | RPL17 (Homo sapiens) | 6480464 | Doxorubicin affects the expression of RPL17 protein | CTD | PMID:29385562 | Rpl17 | Rat | doxorubicin | decreases expression | ISO | RPL17 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of RPL17 mRNA | CTD | PMID:29803840 | Rpl17 | Rat | enzyme inhibitor | multiple interactions | ISO | RPL17 (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation more ... | CTD | PMID:23301498 | Rpl17 | Rat | ethanol | multiple interactions | ISO | Rpl17 (Mus musculus) | 6480464 | Ethanol affects the expression of and affects the splicing of RPL17 mRNA | CTD | PMID:30319688 | Rpl17 | Rat | fenpyroximate | increases expression | ISO | RPL17 (Homo sapiens) | 6480464 | fenpyroximate results in increased expression of RPL17 mRNA | CTD | PMID:33512557 | Rpl17 | Rat | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of RPL17 mRNA | CTD | PMID:24136188 | Rpl17 | Rat | folic acid | decreases expression | ISO | Rpl17 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of RPL17 mRNA | CTD | PMID:25629700 | Rpl17 | Rat | folic acid | multiple interactions | ISO | Rpl17 (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RPL17 mRNA | CTD | PMID:22206623 | Rpl17 | Rat | formaldehyde | decreases expression | ISO | RPL17 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of RPL17 mRNA | CTD | PMID:20655997 | Rpl17 | Rat | FR900359 | decreases phosphorylation | ISO | RPL17 (Homo sapiens) | 6480464 | FR900359 results in decreased phosphorylation of RPL17 protein | CTD | PMID:37730182 | Rpl17 | Rat | fulvestrant | multiple interactions | ISO | RPL17 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of RPL17 gene | CTD | PMID:31601247 | Rpl17 | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of RPL17 mRNA | CTD | PMID:22061828 | Rpl17 | Rat | hydralazine | multiple interactions | ISO | RPL17 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL17 mRNA | CTD | PMID:17183730 | Rpl17 | Rat | indole-3-methanol | affects expression | EXP | | 6480464 | indole-3-carbinol affects the expression of RPL17 mRNA | CTD | PMID:21396975 | Rpl17 | Rat | indometacin | multiple interactions | ISO | RPL17 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Rpl17 | Rat | ivermectin | decreases expression | ISO | RPL17 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of RPL17 protein | CTD | PMID:32959892 | Rpl17 | Rat | L-ethionine | affects expression | EXP | | 6480464 | Ethionine affects the expression of RPL17 mRNA | CTD | PMID:19483382 | Rpl17 | Rat | lead diacetate | affects expression | EXP | | 6480464 | lead acetate affects the expression of RPL17 protein | CTD | PMID:36539177 | Rpl17 | Rat | methapyrilene | increases expression | EXP | | 6480464 | Methapyrilene results in increased expression of RPL17 mRNA | CTD | PMID:15890375 | Rpl17 | Rat | methyl methanesulfonate | decreases expression | ISO | RPL17 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of RPL17 mRNA | CTD | PMID:23649840 | Rpl17 | Rat | methylmercury chloride | increases expression | ISO | RPL17 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of RPL17 mRNA | CTD | PMID:34089799 | Rpl17 | Rat | miconazole | increases expression | ISO | Rpl17 (Mus musculus) | 6480464 | Miconazole results in increased expression of RPL17 mRNA | CTD | PMID:27462272 | Rpl17 | Rat | N-nitrosodiethylamine | increases expression | ISO | Rpl17 (Mus musculus) | 6480464 | Diethylnitrosamine results in increased expression of RPL17 mRNA | CTD | PMID:17942915 | Rpl17 | Rat | N-nitrosodiethylamine | multiple interactions | ISO | Rpl17 (Mus musculus) | 6480464 | MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of RPL17 mRNA] | CTD | PMID:17942915 | Rpl17 | Rat | N-nitrosodimethylamine | increases expression | EXP | | 6480464 | Dimethylnitrosamine results in increased expression of RPL17 mRNA | CTD | PMID:15890375 | Rpl17 | Rat | nefazodone | increases expression | EXP | | 6480464 | nefazodone results in increased expression of RPL17 mRNA | CTD | PMID:24136188 | Rpl17 | Rat | nimesulide | increases expression | EXP | | 6480464 | nimesulide results in increased expression of RPL17 mRNA | CTD | PMID:24136188 | Rpl17 | Rat | omeprazole | affects expression | EXP | | 6480464 | Omeprazole affects the expression of RPL17 mRNA | CTD | PMID:19483382 | Rpl17 | Rat | ozone | multiple interactions | ISO | RPL17 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... | CTD | PMID:32699268|PMID:32845096 | Rpl17 | Rat | paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of RPL17 mRNA | CTD | PMID:32680482 | Rpl17 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Rpl17 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RPL17 mRNA; [perfluorooctane sulfonic more ... | CTD | PMID:36331819 | Rpl17 | Rat | perfluorooctanoic acid | increases expression | ISO | RPL17 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in increased expression of RPL17 protein | CTD | PMID:26879310 | Rpl17 | Rat | picoxystrobin | increases expression | ISO | RPL17 (Homo sapiens) | 6480464 | picoxystrobin results in increased expression of RPL17 mRNA | CTD | PMID:33512557 | Rpl17 | Rat | piperonyl butoxide | increases expression | EXP | | 6480464 | Piperonyl Butoxide results in increased expression of RPL17 mRNA | CTD | PMID:15890375 | Rpl17 | Rat | pirinixic acid | affects expression | EXP | | 6480464 | pirinixic acid affects the expression of RPL17 mRNA | CTD | PMID:19483382 | Rpl17 | Rat | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of RPL17 mRNA | CTD | PMID:15890375 | Rpl17 | Rat | pyrimidifen | increases expression | ISO | RPL17 (Homo sapiens) | 6480464 | pyrimidifen results in increased expression of RPL17 mRNA | CTD | PMID:33512557 | Rpl17 | Rat | rotenone | increases expression | ISO | RPL17 (Homo sapiens) | 6480464 | Rotenone results in increased expression of RPL17 mRNA | CTD | PMID:33512557 | Rpl17 | Rat | SB 431542 | multiple interactions | ISO | RPL17 (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RPL17 more ... | CTD | PMID:37664457 | Rpl17 | Rat | sodium arsenate | decreases expression | ISO | RPL17 (Homo sapiens) | 6480464 | sodium arsenate results in decreased expression of RPL17 protein | CTD | PMID:38348393 | Rpl17 | Rat | sodium arsenite | increases expression | ISO | Rpl17 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of RPL17 mRNA | CTD | PMID:39515575 | Rpl17 | Rat | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of RPL17 mRNA | CTD | PMID:35314868 | Rpl17 | Rat | sodium arsenite | multiple interactions | ISO | RPL17 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of and results in increased activity of RPL17 protein | CTD | PMID:30528433 | Rpl17 | Rat | sodium arsenite | decreases expression | ISO | RPL17 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of RPL17 mRNA | CTD | PMID:38568856|PMID:39719251 | Rpl17 | Rat | sodium fluoride | decreases expression | ISO | Rpl17 (Mus musculus) | 6480464 | Sodium Fluoride results in decreased expression of RPL17 protein | CTD | PMID:28918527 | Rpl17 | Rat | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of RPL17 mRNA | CTD | PMID:30723492|PMID:31150632 | Rpl17 | Rat | thioacetamide | affects expression | EXP | | 6480464 | Thioacetamide affects the expression of RPL17 mRNA | CTD | PMID:19483382 | Rpl17 | Rat | thiram | decreases expression | ISO | RPL17 (Homo sapiens) | 6480464 | Thiram results in decreased expression of RPL17 mRNA | CTD | PMID:38568856 | Rpl17 | Rat | tungsten | increases expression | ISO | Rpl17 (Mus musculus) | 6480464 | Tungsten results in increased expression of RPL17 mRNA | CTD | PMID:30912803 | Rpl17 | Rat | valproic acid | affects expression | ISO | Rpl17 (Mus musculus) | 6480464 | Valproic Acid affects the expression of RPL17 mRNA | CTD | PMID:17963808 | Rpl17 | Rat | valproic acid | multiple interactions | ISO | RPL17 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL17 mRNA | CTD | PMID:17183730 | Rpl17 | Rat | vincristine | decreases expression | ISO | RPL17 (Homo sapiens) | 6480464 | Vincristine results in decreased expression of RPL17 mRNA | CTD | PMID:23649840 | |






















